BPG is committed to discovery and dissemination of knowledge

First published: May 7, 2018


International Conference on Drug Discovery & Translational Medicine 2018

The emergence of new technologies, advances in genetics, and availability of health data have given rise to the era of precision medicine. Precise, personalised patient care is now a clinical reality. It is fundamentally impacting the process of drug discovery and development. Of late, leading pharma/biopharma companies are increasing their investment in personalised medicine. As part of the effort in seizing opportunities and addressing challenges of precision medicine, the International Conference on Drug Discovery and Translational Medicine 2018 (ICDDTM’18) serves as a platform to explore these three perspectives:

(1) Drug Discovery and Development from Preclinical Research to Clinical Trials

(2) Complementary Medicine and Emerging Therapeutic Approach

(3) Translational and Personalised Medicine


When: December 3–5, 2018

Location: Putrajaya

Country: Malaysia

Organizer(s): Malaysian Association for Cancer Research

Email: jstanslas@yahoo.co.uk

Website: https://icddtm18.macr-cancer.org/